Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs MULL✓SelectedUSD · MULLGSK vs MULL performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs MULL

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+46.9%
MULL return
+647.3%
Excess return
-600.4%
Maximum drawdown
-22.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMULLExcessAlpha
1D-0.1%-27.9%+27.8%-0.3%
7D-5.3%-43.8%+38.5%-5.6%
30D-3.7%-63.3%+59.6%-4.2%
3M-7.3%-70.1%+62.8%-7.8%
6M-4.2%-62.5%+58.3%-5.4%
YTD+0.9%+86.8%-85.9%-3.6%
1Y+7.3%+254.7%-247.4%+1.0%
All+46.9%+647.3%-600.4%+32.4%

Cumulative growth

Daily Returns

Daily percentage return beside MULL.

Daily Out/Under-Performance

Portfolio return minus MULL return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MULL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MULL wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling